
Ardian’s Novacap in €310m refinancing
Ardian-backed French chemicals group Novacap has completed a €310m refinancing on the high-yield bond market.
The issue comprises €310m of senior secured floating rate notes, to mature in 2019. The notes have an interest rate equal to three-month Euribor plus 5% per year.
The company has also secured a €65m super-senior revolving credit facility.
Goldman Sachs acted as the lead bookrunner for the refinancing, with support from Deutsche Bank, BNP Paribas and Societe Generale.
The refinancing will allow Novacap to continue its ongoing buy-and-build growth strategy under Ardian's ownership.
Previous investment
Ardian (then Axa Private Equity) acquired a 96% stake in Novacap in January 2011. The firm bought the business from Bain Capital via a Rothschild-run auction process. The transaction valued Novacap at €240m.
Ardian invested via its €1.6bn Axa LBO Fund IV. According to unquote" data, a €209m debt package was supplied by BNP Paribas, Societe Generale and HSBC for the buyout.
The GP then supplied acquisition financing to Novacap in November 2011 for the purchase of French chemical group Rhodia's salicylic and acetaminophen businesses, which were renamed Novacyl.
Last year Novacap also acquired a 51% stake in Taixing Yangzi Pharm Chemical, a Chinese producer of para-aminophenol, the main raw material used for the production of paracetamol.
Bain had acquired Novacap in November 2012 for €150m, spinning it out as the European commercial and industrial activities division of Rhodia. A mezzanine facility of €10m was supplied by JP Morgan Private Equity, according to unquote" data.
Company
Lyon-headquartered Novacap produces speciality chemicals for the pharmaceutical, food, animal feed, cosmetics, fragrances and homecare sectors. The group comprises three divisions: mineral specialities, pharmaceuticals and cosmetics, and performance chemicals.
The company employs 1,245 staff and operates 11 facilities worldwide. Novacap claims to have 650 customers across 80 countries.
People
Pierre Luzeau is the president of Novacap. Managing director Thibault Basquin, director Olivier Personnaz, and senior investment manager Arnaud Tardan worked on the transaction for Ardian.
Advisers
Ardian – Latham & Watkins, Thomas Forschbach, Gaetan Gianasso, Natacha Guelibolian (Legal).
Company – White & Case, Colin Chang, Julien Chameyrat, Camille Note (Legal); Latham & Watkins, Olivia Rauch-Ravise, Mathieu Denieau (Legal); PwC Transaction Services, Philippe Gueguen, Philippe Chavanne (Corporate finance).
Management – Opleo Avocats, Pierre-Olivier Bernard, Antoine Degorce (Legal).
Debt – Milbank, Peter Schwartz, Laetitia Costa (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater